Filter
610
Filtered Results: 610
Text search:
molecular
markers
Featured
Recommendations
75
New Publications
127
Language
Document type
No document type
274
Guidelines
123
Studies & Reports
122
Manuals
42
Strategic & Response Plan
23
Training Material
10
Fact sheets
10
Situation Updates
5
Resource Platforms
1
Countries / Regions
India
52
Global
25
Kenya
15
Latin America and the Carribbean
15
Tanzania
15
Africa
14
Western and Central Europe
12
Ethiopia
10
Nigeria
8
South Africa
8
Eastern Europe
8
South–East Asia Region
6
Uganda
6
Sierra Leone
5
Zimbabwe
5
Philippines
5
West and Central Africa
5
East and Southern Africa
5
Ukraine
4
Malawi
4
Asia
4
Western Pacific Region
4
Indonesia
4
Nepal
3
Cameroon
3
Congo, Democratic Republic of
3
Brazil
3
Myanmar / Burma
3
Pakistan
3
Ghana
2
Benin
2
Syria
2
Burkina Faso
2
Guinea
2
USA
2
Venezuela
2
Middle East and North Africa
2
North America
2
Bangladesh
2
Zambia
2
Liberia
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Lesotho
1
China
1
Rwanda
1
Senegal
1
Afghanistan
1
Peru
1
Malaysia
1
Cambodia
1
Jordan
1
Germany
1
Eastern Europe and Central Asia
1
Gabon
1
Japan
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Namibia
1
Georgia
1
Angola
1
Chad
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
169
Clinical Guidelines
102
Public Health
41
Pharmacy & Technologies
26
Women & Child Health
15
Key Resources
14
Capacity Building
4
Toolboxes
TB
78
AMR
63
COVID-19
60
HIV
39
NTDs
34
Rapid Response
31
Mental Health
30
Planetary Health
23
NCDs
17
Ebola
14
Pharmacy
13
Refugee
8
Specific Hazards
6
Global Health Education
6
Zika
5
Polio
5
Conflict
4
Disability
3
Cholera
3
Caregiver
3
Natural Hazards
2
Health Financing Toolbox
2
Social Ethics
1
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status—wealth and education—differ among...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
Towards universal access
Dermatological Preparations For The Tropics
recommended
A formulary of dermatological preparations and background information on therapeutic choices, production and dispensing. 2nd edition
Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/
Policy framework.
Suggested language and usage for tuberculosis communications
First edition
Accessed November 2017
